2022 Regular Session • Maryland Legislature
HB1355: Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance
Legislative Summary
Requiring health insurance carriers to limit the amount a covered individual is required to pay in copayments or coinsurance for a covered prescription insulin drug to $30 for a 30-day supply; and requiring the Prescription Drug Affordability Board to conduct a certain cost review of prescription insulin drug products.
Bill History
2/11/2022
First Reading Health and Government Operations
House of Delegates
2/14/2022
Hearing 3/03 at 1:30 p.m.
House of Delegates
Status Information
Current Status
Introduced(2/11/2022)
Chamber
House of Delegates
Committee
Health and Government Operations(House of Delegates)
Sine Die
Sponsors
Republican: 5
Primary Sponsor
Dan Cox
Republican